reference/322063

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/322063

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article
endingPage	516
issn	1432-0584 0939-5555
issueIdentifier	8
pageRange	510-516
publicationName	Annals of Hematology
startingPage	510
bibliographicCitation	Pedersen LM, Klausen TW, Davidsen UH, Johnsen HE. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma. Ann Hematol. 2005 Aug;84(8):510–6. doi: 10.1007/s00277-005-1020-x. PMID: 15834569.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5de9a7ee6225934c73780a0926948144 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91b3819034936d8029d75cae3e75eda8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eaae49faba3a9a2b17234f1264ffdb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8253-2913 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b28dce905cb0a1f63012e12acb923694
date	2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15834569 https://doi.org/10.1007/s00277-005-1020-x
isPartOf	https://portal.issn.org/resource/ISSN/0939-5555 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088 https://portal.issn.org/resource/ISSN/1432-0584
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0024272 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0006784
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 50.